Amicus Therapeutics (FOLD) leaps on positive updates

Amicus Therapeutics, Inc FOLD shares surged 27.3% to $11.90 on announcement of positive global regulatory updates from the EMA and the FDA meetings for Fabry monotherapy. Share volume was 1.5 million, or nearly five times its all-day average